Application no. and date | 07728833.0 (espacenet) (Federated) (European Patent Register), 20070507 | Patent/reg. no. and date | DK/EP 2021006, 20150812 | Publication date | 20090211 | Priority no. and date | US 746817 P, 20060509, US 830987 P, 20060714 | EP pub. no. and date |
EP 2021006 20090211 | Effective date | | Applicant/owner | Sprout Pharmaceuticals, Inc., 4208 Six Forks Road, Suite 1010
Raleigh, NC 27609, US | Applicant ref. no. | T5055DK00 | Inventor | POLLENTIER, Stephane, Boschmansweg 17
1871 AW Schoorl, NL, PYKE, Robert, Boehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road
P.O.Box 368 Ridgefield, CT 06877, US | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | Opponent | | IPC Class | A61K 31/496 (2006.01) , A61P 15/00 (2006.01) , A61P 15/12 (2006.01) | Title | ANVENDELSE AF FLIBANSERIN TIL BEHANDLING AF POSTMENOPAUSALE SEXLYSTFORSTYRRELSER | Int. application no. | EP2007054380 | Int. publication no. | WO2007128802 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|